Correlation Between Rocket Pharmaceuticals and Connect Biopharma
Can any of the company-specific risk be diversified away by investing in both Rocket Pharmaceuticals and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rocket Pharmaceuticals and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rocket Pharmaceuticals and Connect Biopharma Holdings, you can compare the effects of market volatilities on Rocket Pharmaceuticals and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rocket Pharmaceuticals with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rocket Pharmaceuticals and Connect Biopharma.
Diversification Opportunities for Rocket Pharmaceuticals and Connect Biopharma
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Rocket and Connect is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Rocket Pharmaceuticals and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Rocket Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rocket Pharmaceuticals are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Rocket Pharmaceuticals i.e., Rocket Pharmaceuticals and Connect Biopharma go up and down completely randomly.
Pair Corralation between Rocket Pharmaceuticals and Connect Biopharma
Given the investment horizon of 90 days Rocket Pharmaceuticals is expected to generate 0.74 times more return on investment than Connect Biopharma. However, Rocket Pharmaceuticals is 1.36 times less risky than Connect Biopharma. It trades about -0.28 of its potential returns per unit of risk. Connect Biopharma Holdings is currently generating about -0.23 per unit of risk. If you would invest 1,749 in Rocket Pharmaceuticals on August 28, 2024 and sell it today you would lose (339.00) from holding Rocket Pharmaceuticals or give up 19.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rocket Pharmaceuticals vs. Connect Biopharma Holdings
Performance |
| Timeline |
| Rocket Pharmaceuticals |
| Connect Biopharma |
Rocket Pharmaceuticals and Connect Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rocket Pharmaceuticals and Connect Biopharma
The main advantage of trading using opposite Rocket Pharmaceuticals and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rocket Pharmaceuticals position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.| Rocket Pharmaceuticals vs. Eliem Therapeutics | Rocket Pharmaceuticals vs. HCW Biologics | Rocket Pharmaceuticals vs. Scpharmaceuticals | Rocket Pharmaceuticals vs. Milestone Pharmaceuticals |
| Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |